These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 625059)

  • 1. The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with Ile-Val at 1.9 A resolution.
    Bode W; Schwager P; Huber R
    J Mol Biol; 1978 Jan; 118(1):99-112. PubMed ID: 625059
    [No Abstract]   [Full Text] [Related]  

  • 2. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
    Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
    J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The refined 2.2-A (0.22-nm) X-ray crystal structure of the ternary complex formed by bovine trypsinogen, valine-valine and the Arg15 analogue of bovine pancreatic trypsin inhibitor.
    Bode W; Walter J; Huber R; Wenzel HR; Tschesche H
    Eur J Biochem; 1984 Oct; 144(1):185-90. PubMed ID: 6207021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen exchange kinetics of bovine pancreatic trypsin inhibitor beta-sheet protons in trypsin-bovine pancreatic trypsin inhibitor, trypsinogen-bovine pancreatic trypsin inhibitor, and trypsinogen-isoleucylvaline-bovine pancreatic trypsin inhibitor.
    Brandt P; Woodward C
    Biochemistry; 1987 Jun; 26(11):3156-67. PubMed ID: 2440473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the Ile-Val and Val-Val effector dipeptides to the binary adducts of bovine trypsinogen with Kunitz and Kazal inhibitors as well as the acylating agent p-nitrophenyl p-guanidinobenzoate. A thermodynamic and kinetic study.
    Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
    J Mol Biol; 1987 Apr; 194(4):751-4. PubMed ID: 2443709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine trypsinogen activation. A thermodynamic study.
    Coletta M; Ascenzi P; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
    Biophys Chem; 1990 Aug; 37(1-3):355-62. PubMed ID: 2285797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypsin activation. Effect of the Ile-Val dipeptide concentration on Kazal inhibitor binding to bovine trypsinogen.
    Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
    Biochim Biophys Acta; 1985 Dec; 832(3):378-82. PubMed ID: 4074755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between squash inhibitors and bovine trypsinogen.
    Zbyryt T; Otlewski J
    Biol Chem Hoppe Seyler; 1991 Apr; 372(4):255-62. PubMed ID: 2059335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 A resolution. Structure solution, crystallographic refinement and preliminary structural interpretation.
    Bolognesi M; Gatti G; Menagatti E; Guarneri M; Marquart M; Papamokos E; Huber R
    J Mol Biol; 1982 Dec; 162(4):839-68. PubMed ID: 7169635
    [No Abstract]   [Full Text] [Related]  

  • 10. Structure of bovine trypsinogen at 1.9 A resolution.
    Kossiakoff AA; Chambers JL; Kay LM; Stroud RM
    Biochemistry; 1977 Feb; 16(4):654-64. PubMed ID: 556951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic and ligand binding properties of bovine trypsinogen and its complex with the effector dipeptide Ile-Val. A comparative study.
    Antonini E; Ascenzi P; Bolognesi M; Guarneri M; Menegatti E; Amiconi G
    Mol Cell Biochem; 1984; 60(2):163-81. PubMed ID: 6708945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denaturation of free and complexed bovine trypsinogen with the calcium ion, dipeptide Ile-Val and basic pancreatic trypsin inhibitor (Kunitz).
    Bulaj G; Otlewski J
    Eur J Biochem; 1994 Aug; 223(3):939-46. PubMed ID: 7519988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of bovine trypsinogen at 1-8 A resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin.
    Fehlhammer H; Bode W; Huber R
    J Mol Biol; 1977 Apr; 111(4):415-38. PubMed ID: 864704
    [No Abstract]   [Full Text] [Related]  

  • 14. High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes.
    Helland R; Berglund GI; Otlewski J; Apostoluk W; Andersen OA; Willassen NP; Smalås AO
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):139-48. PubMed ID: 10089404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of the bovine pancreatic secretory trypsin inhibitor (Kazal) to bovine serine (pro)enzymes.
    Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
    J Mol Biol; 1987 Nov; 198(1):129-32. PubMed ID: 3430603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating effect of the Ile-Val dipeptide on the catalytic properties of bovine trypsinogen.
    Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
    Biochim Biophys Acta; 1985 Nov; 832(1):1-6. PubMed ID: 4052434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. II. The binding of the pancreatic trypsin inhibitor and of isoleucine-valine and of sequentially related peptides to trypsinogen and to p-guanidinobenzoate-trypsinogen.
    Bode W
    J Mol Biol; 1979 Feb; 127(4):357-74. PubMed ID: 311834
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbon-13 nuclear magnetic resonance studies of the selectively isotope-labeled reactive site peptide bond of the basic pancreatic trypsin inhibitor in the complexes with trypsin, trypsinogen, and anhydrotrypsin.
    Richarz R; Tschesche H; Wüthrich K
    Biochemistry; 1980 Dec; 19(25):5711-5. PubMed ID: 6161642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crystal and molecular structure of DIP-inhibited bovine trypsin at2.7Angstrom resolution.
    Stroud RM; Kay LM; Dickerson RE
    Cold Spring Harb Symp Quant Biol; 1972; 36():125-40. PubMed ID: 4508129
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of anionic and cationic trypsinogens: the anionic activation domain is more flexible in solution and differs in its mode of BPTI binding in the crystal structure.
    Pasternak A; Ringe D; Hedstrom L
    Protein Sci; 1999 Jan; 8(1):253-8. PubMed ID: 10210204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.